171 related articles for article (PubMed ID: 19073174)
1. Involvement of anoikis-resistance in the metastasis of hepatoma cells.
Cao L; Han L; Zhang Z; Li J; Qu Z; Du J; Liang X; Liu Y; Liu H; Shi Y; Liu S; Gao L; Sun W
Exp Cell Res; 2009 Apr; 315(7):1148-56. PubMed ID: 19073174
[TBL] [Abstract][Full Text] [Related]
2. Acquisition of anoikis resistance reveals a synoikis-like survival style in BEL7402 hepatoma cells.
Zhang Z; Cao L; Li J; Liang X; Liu Y; Liu H; Du J; Qu Z; Cui M; Liu S; Gao L; Ma C; Zhang L; Han L; Sun W
Cancer Lett; 2008 Aug; 267(1):106-15. PubMed ID: 18433990
[TBL] [Abstract][Full Text] [Related]
3. Carcinoembryonic antigen inhibits anoikis in colorectal carcinoma cells by interfering with TRAIL-R2 (DR5) signaling.
Samara RN; Laguinge LM; Jessup JM
Cancer Res; 2007 May; 67(10):4774-82. PubMed ID: 17510406
[TBL] [Abstract][Full Text] [Related]
4. DR5 receptor mediates anoikis in human colorectal carcinoma cell lines.
Laguinge LM; Samara RN; Wang W; El-Deiry WS; Corner G; Augenlicht L; Mishra L; Jessup JM
Cancer Res; 2008 Feb; 68(3):909-17. PubMed ID: 18245494
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta-mediated tumor necrosis factor-related apoptosis-inducing ligand expression and apoptosis in hepatoma cells requires functional cooperation between Smad proteins and activator protein-1.
Herzer K; Grosse-Wilde A; Krammer PH; Galle PR; Kanzler S
Mol Cancer Res; 2008 Jul; 6(7):1169-77. PubMed ID: 18644981
[TBL] [Abstract][Full Text] [Related]
6. TRAIL resistance of breast cancer cells is associated with constitutive endocytosis of death receptors 4 and 5.
Zhang Y; Zhang B
Mol Cancer Res; 2008 Dec; 6(12):1861-71. PubMed ID: 19074831
[TBL] [Abstract][Full Text] [Related]
7. Genistein sensitizes human hepatocellular carcinoma cells to TRAIL-mediated apoptosis by enhancing Bid cleavage.
Jin CY; Park C; Moon SK; Kim GY; Kwon TK; Lee SJ; Kim WJ; Choi YH
Anticancer Drugs; 2009 Sep; 20(8):713-22. PubMed ID: 19617819
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system.
Zhu H; Dong H; Eksioglu E; Hemming A; Cao M; Crawford JM; Nelson DR; Liu C
Gastroenterology; 2007 Nov; 133(5):1649-59. PubMed ID: 17983809
[TBL] [Abstract][Full Text] [Related]
9. Mitogen-activated protein kinase pathway is pivotal for anoikis resistance in metastatic hepatoma cells.
Cao L; Zhang Z; Han L; Du J; Liang X; Liu Y; Sun W
Mol Med Rep; 2014 Apr; 9(4):1121-7. PubMed ID: 24535322
[TBL] [Abstract][Full Text] [Related]
10. Expression of HBX, an oncoprotein of hepatitis B virus, blocks reoviral oncolysis of hepatocellular carcinoma cells.
Park EH; Koh SS; Srisuttee R; Cho IR; Min HJ; Jhun BH; Lee YS; Jang KL; Kim CH; Johnston RN; Chung YH
Cancer Gene Ther; 2009 May; 16(5):453-61. PubMed ID: 19096445
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors in renal cell cancer.
Macher-Goeppinger S; Aulmann S; Tagscherer KE; Wagener N; Haferkamp A; Penzel R; Brauckhoff A; Hohenfellner M; Sykora J; Walczak H; Teh BT; Autschbach F; Herpel E; Schirmacher P; Roth W
Clin Cancer Res; 2009 Jan; 15(2):650-9. PubMed ID: 19147771
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the sodium potassium adenosine triphosphatase pump sensitizes cancer cells to anoikis and prevents distant tumor formation.
Simpson CD; Mawji IA; Anyiwe K; Williams MA; Wang X; Venugopal AL; Gronda M; Hurren R; Cheng S; Serra S; Beheshti Zavareh R; Datti A; Wrana JL; Ezzat S; Schimmer AD
Cancer Res; 2009 Apr; 69(7):2739-47. PubMed ID: 19293189
[TBL] [Abstract][Full Text] [Related]
13. TRAIL as a target in anti-cancer therapy.
Wu GS
Cancer Lett; 2009 Nov; 285(1):1-5. PubMed ID: 19299078
[TBL] [Abstract][Full Text] [Related]
14. Glycogen synthase kinase-3 inhibitors augment TRAIL-induced apoptotic death in human hepatoma cells.
Beurel E; Blivet-Van Eggelpoël MJ; Kornprobst M; Moritz S; Delelo R; Paye F; Housset C; Desbois-Mouthon C
Biochem Pharmacol; 2009 Jan; 77(1):54-65. PubMed ID: 18938143
[TBL] [Abstract][Full Text] [Related]
15. TRAIL-induced apoptosis of FHIT-negative lung cancer cells is inhibited by FHIT re-expression.
Mirandola P; Gobbi G; Sponzilli I; Malinverno C; Cavazzoni A; Alfieri R; Petronini PG; Vitale M
J Cell Physiol; 2009 Aug; 220(2):492-8. PubMed ID: 19418484
[TBL] [Abstract][Full Text] [Related]
16. Is there a role for nuclear factor kappaB in tumor necrosis factor-related apoptosis-inducing ligand resistance?
Plantivaux A; Szegezdi E; Samali A; Egan L
Ann N Y Acad Sci; 2009 Aug; 1171():38-49. PubMed ID: 19723036
[TBL] [Abstract][Full Text] [Related]
17. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.
Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J
Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708
[TBL] [Abstract][Full Text] [Related]
18. Genistein enhances TRAIL-induced apoptosis through inhibition of p38 MAPK signaling in human hepatocellular carcinoma Hep3B cells.
Jin CY; Park C; Kim GY; Lee SJ; Kim WJ; Choi YH
Chem Biol Interact; 2009 Jul; 180(2):143-50. PubMed ID: 19497411
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis and cancer stem cells: Implications for apoptosis targeted therapy.
Kruyt FA; Schuringa JJ
Biochem Pharmacol; 2010 Aug; 80(4):423-30. PubMed ID: 20394737
[TBL] [Abstract][Full Text] [Related]
20. Anoikis resistance and tumor metastasis.
Simpson CD; Anyiwe K; Schimmer AD
Cancer Lett; 2008 Dec; 272(2):177-85. PubMed ID: 18579285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
